ID
40120
Description
Study ID: 110852 Clinical Study ID: 110852 Study Title: MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01134055 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: pazopanib eye drops, ranibizumab intravitreal injection, placebo Trade Name: pazopanib, ranibizumab Study Indication: Macular Degeneration
Keywords
Versions (1)
- 3/12/20 3/12/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
March 12, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration NCT01134055
Status of Treatment Mask; Investigational Product Discontinuation; Pregnancy Information; Investigational Product (Eye Drops) - Last Dose Date; Study Conclusion
Description
Investigational Product Discontinuation
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C0457454
Description
Yes, complete primary reason
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0457454
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C1948053
- UMLS CUI [2,3]
- C0205539
- UMLS CUI [2,4]
- C0444930
- UMLS CUI [2,5]
- C0332152
Description
Select primary reason the investigational product was stopped
Data type
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0013230
- UMLS CUI [1,3]
- C0457454
Description
Record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons":
Data type
text
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C2348235
Description
Select this reason if none of the other primary reasons are appropriate.
Data type
text
Alias
- UMLS CUI [1,1]
- C0008961
- UMLS CUI [1,2]
- C0022423
- UMLS CUI [1,3]
- C2348235
Description
Select this reason if none of the other primary reasons are appropriate. Check all that apply. If none, select "No Subreasons":
Data type
text
Alias
- UMLS CUI [1,1]
- C0679006
- UMLS CUI [1,2]
- C0681850
- UMLS CUI [1,3]
- C0600420
- UMLS CUI [1,4]
- C2348235
Description
If other decision by subject or proxy, specify
Data type
text
Alias
- UMLS CUI [1,1]
- C0679006
- UMLS CUI [1,2]
- C0681850
- UMLS CUI [1,3]
- C0600420
- UMLS CUI [1,4]
- C0205394
- UMLS CUI [1,5]
- C2348235
Description
Pregnancy Information
Alias
- UMLS CUI-1
- C0032961
- UMLS CUI-2
- C1533716
Description
Investigational Product (Eye Drops) - Last Dose Date
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C0015399
- UMLS CUI-3
- C1762893
Description
Study Conclusion
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008972
Description
Date of subject completion or withdrawal
Data type
date
Alias
- UMLS CUI [1]
- C2983670
Description
Was the subject withdrawn from the study?
Data type
text
Alias
- UMLS CUI [1]
- C0422727
Description
Primary reason for withdrawal
Data type
integer
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0392360
Description
Record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons":
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0392360
- UMLS CUI [1,3]
- C2349954
Description
Select this reason if none of the other primary reasons are appropriate
Data type
text
Alias
- UMLS CUI [1,1]
- C2348235
- UMLS CUI [1,2]
- C0008961
- UMLS CUI [1,3]
- C0022423
Description
Select this reason if none of the other primary reasons are appropriate. Check all that apply. If none, select "No Subreasons":
Data type
text
Alias
- UMLS CUI [1,1]
- C1707492
- UMLS CUI [1,2]
- C2348235
Similar models
Status of Treatment Mask; Investigational Product Discontinuation; Pregnancy Information; Investigational Product (Eye Drops) - Last Dose Date; Study Conclusion
C2347038 (UMLS CUI-2)
C0011008 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C0205394 (UMLS CUI [2,1])
C2348235 (UMLS CUI [2,2])
C0457454 (UMLS CUI-2)
C0457454 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1948053 (UMLS CUI [2,2])
C0205539 (UMLS CUI [2,3])
C0444930 (UMLS CUI [2,4])
C0332152 (UMLS CUI [2,5])
C0013230 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,2])
C0022423 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0681850 (UMLS CUI [1,2])
C0600420 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0681850 (UMLS CUI [1,2])
C0600420 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
C0015399 (UMLS CUI-2)
C1762893 (UMLS CUI-3)
C0392360 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,3])
C0008961 (UMLS CUI [1,2])
C0022423 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,2])